UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Surgery with emicizumab prophylaxis for two paediatric patients with severe haemophilia A with inhibitors

Pediatric blood & cancer, 2021-07, Vol.68 (7), p.e29041-n/a

2021

Volltextzugriff (PDF)

Effect of heparin thromboprophylaxis on thrombin generation in multiple myeloma patients

British journal of haematology, 2019-07, Vol.186 (2), p.337-339

2019

Volltextzugriff (PDF)

Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-05, Vol.30 (3), p.693-701

2024

Volltextzugriff (PDF)

Heparin‐induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation

Journal of thrombosis and haemostasis, 2021-08, Vol.19 (8), p.1959-1972

2021

Volltextzugriff (PDF)

Tissue factor pathway inhibitor is the main determinant of thrombin generation in haemophilic patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-03, Vol.25 (2), p.343-348

2019

Volltextzugriff (PDF)

PHILEOS (haemoPHILia and ostEoporOSis) Study: protocol of a multicentre prospective case–control study

BMJ open, 2021-01, Vol.11 (1), p.e042283-e042283

2021

Volltextzugriff (PDF)

Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: An observational cohort study

Research and practice in thrombosis and haemostasis, 2019-01, Vol.3 (1), p.89-98

2019

Volltextzugriff (PDF)

Switch to pdVWF:pdFVIII concentrate for prophylaxis in a paediatric patient with Type 3 von Willebrand disease: a case report

Hematology, 2023-12, Vol.28 (1), p.2186332-2186332

2023

Volltextzugriff (PDF)

Use of population PK/PD approach to model the thrombin generation assay: assessment in haemophilia A plasma samples spiked by a TFPI antibody

Journal of pharmacokinetics and pharmacodynamics, 2021-08, Vol.48 (4), p.563-580

2021

Volltextzugriff (PDF)

Functional Flow Cytometric Assay for Reliable and Convenient Heparin-Induced Thrombocytopenia Diagnosis in Daily Practice

Biomedicines, 2021-03, Vol.9 (4), p.332

2021

Volltextzugriff (PDF)

Extremely low doses of lepirudin in a patient with heparin‐induced thrombocytopenia, high bleeding risk and renal insufficiency

British journal of haematology, 2009-08, Vol.146 (4), p.456-457

2009

Volltextzugriff (PDF)

Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial

Thrombosis and haemostasis, 2003-03, Vol.89 (3), p.458

2003

Volltextzugriff (PDF)

Patient-Specific Modelling of Blood Coagulation

Bulletin of mathematical biology, 2021-03, Vol.83 (5), p.50-50, Article 50

2021

Volltextzugriff (PDF)

Clinical characteristics and laboratory testing of patients with suspected HIT: A survey on current practice in 11 university hospitals in France

Thrombosis research, 2010-06, Vol.125 (6), p.e294-e299

2010

Volltextzugriff (PDF)

Efficacy and Safety of Danaparoid Sodium (ORG 10172) in Critically Ill Patients With Heparin-Associated Thrombocytopenia

Chest, 1999-06, Vol.115 (6), p.1616-1620

1999

Volltextzugriff (PDF)

Clustering of Thrombin Generation Test Data Using a Reduced Mathematical Model of Blood Coagulation

Acta biotheoretica, 2020-03, Vol.68 (1), p.21-43

2020

Volltextzugriff (PDF)

Thrombin generation and heparin‐induced thrombocytopenia

Journal of thrombosis and haemostasis, 2009-09, Vol.7 (9), p.1474-1481

2009

Volltextzugriff (PDF)

Effects of argatroban, danaparoid, and fondaparinux on trombin generation in heparin-induced thrombocytopenia

Thrombosis and haemostasis, 2013-03, Vol.109 (3), p.504

2013

Volltextzugriff (PDF)

Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study

Journal of thrombosis and haemostasis, 2023-08, Vol.21 (8), p.2126-2136

2023

Volltextzugriff (PDF)

Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses

Thrombosis and haemostasis, 1998-09, Vol.80 (3), p.530

1998

Volltextzugriff (PDF)

Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia

Thrombosis research, 2009-11, Vol.124 (5), p.554-559

2009

Volltextzugriff (PDF)

Evaluation and Calibration of In Silico Models of Thrombin Generation Using Experimental Data from Healthy and Haemophilic Subjects

Bulletin of mathematical biology, 2018-08, Vol.80 (8), p.1989-2025

2018

Volltextzugriff (PDF)

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial

Critical care (London, England), 2015-11, Vol.19 (396), p.396-396, Article 396

2015

Volltextzugriff (PDF)

Heparin‐induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation

Journal of thrombosis and haemostasis, 2021-08, Vol.19 (8), p.1959-1972

2021

Volltextzugriff (PDF)

Heparin‐induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation

Journal of thrombosis and haemostasis, 2021-08, Vol.19 (8), p.1959-1972

2021

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(42)
Berichte
(1)

Sprache

Englisch
(43)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(34)
Humans
(30)
Hematology
(25)
Life Sciences
(20)
Male
(19)
Female
(18)
Aged
(17)
Middle Aged
(14)
Thrombocytopenia - Chemically Induced
(13)
Cardiovascular System & Cardiology
(12)
Peripheral Vascular Disease
(12)
Biological And Medical Sciences
(11)
Heparin - Adverse Effects
(11)
Adult
(10)
Medical Sciences
(10)
Heparin
(9)
Thrombin
(9)
Thrombocytopenia
(8)
Aged, 80 And Over
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Surgery with emicizumab prophylaxis for two paediatric patients with severe haemophilia A with inhibitors

Effect of heparin thromboprophylaxis on thrombin generation in multiple myeloma patients

Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B

Heparin‐induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation

Tissue factor pathway inhibitor is the main determinant of thrombin generation in haemophilic patients

PHILEOS (haemoPHILia and ostEoporOSis) Study: protocol of a multicentre prospective case–control study

Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: An observational cohort study

Switch to pdVWF:pdFVIII concentrate for prophylaxis in a paediatric patient with Type 3 von Willebrand disease: a case report

Use of population PK/PD approach to model the thrombin generation assay: assessment in haemophilia A plasma samples spiked by a TFPI antibody

Functional Flow Cytometric Assay for Reliable and Convenient Heparin-Induced Thrombocytopenia Diagnosis in Daily Practice

Extremely low doses of lepirudin in a patient with heparin‐induced thrombocytopenia, high bleeding risk and renal insufficiency

Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial

Patient-Specific Modelling of Blood Coagulation

Clinical characteristics and laboratory testing of patients with suspected HIT: A survey on current practice in 11 university hospitals in France

Efficacy and Safety of Danaparoid Sodium (ORG 10172) in Critically Ill Patients With Heparin-Associated Thrombocytopenia

Clustering of Thrombin Generation Test Data Using a Reduced Mathematical Model of Blood Coagulation

Thrombin generation and heparin‐induced thrombocytopenia

Effects of argatroban, danaparoid, and fondaparinux on trombin generation in heparin-induced thrombocytopenia

Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study

Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses

Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia

Evaluation and Calibration of In Silico Models of Thrombin Generation Using Experimental Data from Healthy and Haemophilic Subjects

Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial

Heparin‐induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation

Heparin‐induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation

Suchergebnisse filtern